Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/25696
Title: An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers
Authors: Premi, E
Costa, T
Gazzina, S
Benussi, A
Cauda, F
Gasparotti, R
Archetti, S
Alberici, A
Van Swieten, JC
Sanchez-Valle, R
Moreno, F
Santana, I
Laforce, R
Ducharme, S
Graff, C
Galimberti, D
Masellis, M
Tartaglia, C
Rowe, JB
Finger, E
Tagliavini, F
De Mendonça, A
Vandenberghe, R
Gerhard, A
Butler, CR
Danek, A
Synofzik, M
Levin, J
Otto, M
Ghidoni, R
Frisoni, G
Sorbi, S
Peakman, G
Todd, E
Bocchetta, M
Rohrer, JD
Borroni, B
Keywords: frontotemporal dementia;granulin;magnetic resonance imaging;mutation;preclinical;presymptomatic
Issue Date: 8-Mar-2022
Publisher: IOS Press
Citation: Premi, E. et al. on behalf of the GENFI Consortium Members (2022) 'An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers', Journal of Alzheimer's Disease, 86 (1), pp. 205 - 218. doi: 10.3233/JAD-215447.
Abstract: Background:Magnetic resonance imaging (MRI) measures may be used as outcome markers in frontotemporal dementia (FTD). Objectives:To predict MRI cortical thickness (CT) at follow-up at the single subject level, using brain MRI acquired at baseline in preclinical FTD. Methods:84 presymptomatic subjects carrying Granulin mutations underwent MRI scans at baseline and at follow-up (31.2±16.5 months). Multivariate nonlinear mixed-effects model was used for estimating individualized CT at follow-up based on baseline MRI data. The automated user-friendly preGRN-MRI script was coded. Results:Prediction accuracy was high for each considered brain region (i.e., prefrontal region, real CT at follow-up versus predicted CT at follow-up, mean error ≤1.87%). The sample size required to detect a reduction in decline in a 1-year clinical trial was equal to 52 subjects (power = 0.80, alpha = 0.05). Conclusion:The preGRN-MRI tool, using baseline MRI measures, was able to predict the expected MRI atrophy at follow-up in presymptomatic subjects carrying GRN mutations with good performances. This tool could be useful in clinical trials, where deviation of CT from the predicted model may be considered an effect of the intervention itself.
URI: https://bura.brunel.ac.uk/handle/2438/25696
DOI: https://doi.org/10.3233/JAD-215447
ISSN: 1387-2877
Other Identifiers: ORCID iD: Martina Bocchetta https://orcid.org/0000-0003-1814-5024
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2021 The Authors. Published by IOS Press. This is the author accepted manuscript. This version is free to view and download for private research and study only. Not for re-distribution or re-use. The final publication is available at IOS Press through https://doi.org/10.3233/JAD-215447.996.6 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.